drugset / Trial / NCT06453265
A Study to Assess the Abuse Potential of Intranasal Cebranopadol
RandomizedCrossoverQuadruple-blindTreatment
Summary
The purpose of this study to Assess the Abuse Potential of Intranasal Cebranopadol Compared to Oxycodone and Placebo in Healthy, Nondependent Recreational Opioid Users.
Timeline
- Start
- 2024-06-28
- Primary completion
- 2024-11-06
- Completion
- 2024-11-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cebranopadol | Small molecule | 600 ug | Intranasal |
| Subject | Cebranopadol | Small molecule | 800 ug | Intranasal |
| Subject | Cebranopadol | Small molecule | 1000 ug | Intranasal |
| Comparator | Oxycodone | Other / unclassified | 40 mg | Intranasal |